STOCK-BASED COMPENSATION (Details 1) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Restricted Stock Units, Beginning balance | 55,110,881 | 55,535,881 |
| Restricted Stock Units, Vested | (430,000) | |
| Restricted Stock Units, Ending balance | 55,110,881 | 55,110,881 |
| Equity Classified [Member] | Restricted Stock Units (RSUs) [Member] | ||
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Restricted Stock Units, Beginning balance | 6,526 | 84,862 |
| Restricted Stock Units, Granted | 551,960 | |
| Restricted Stock Units, Vested | (558,488) | (78,336) |
| Restricted Stock Units, Ending balance | 6,526 | |
| Weighted average grant date fair value | $ 0.00 | $ 0.73 |
| Restricted Stock Units, Forfeited | 2 | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares related to Restricted Stock Award forfeited during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|